Night Blindness Treatment Global Market Report 2024

Description

Night blindness treatment involves interventions designed to address conditions such as vitamin A deficiency and other issues that impair vision in low light conditions. The goal is to improve visual acuity in dim settings and overall visual function by targeting the underlying causes. This treatment aims to enhance the patient's ability to see in low-light environments and at night.

The primary treatments available in the night blindness market include medication, surgery, and other therapies. Night blindness medication focuses on improving vision in low-light conditions by addressing underlying issues such as vitamin A deficiency, retinitis pigmentosa, or other retinal disorders. Diagnosis of night blindness can involve various tests including blood tests, color vision testing, pupil light reflex examination, refraction, retinal exams, and electroretinograms (ERG). Symptoms may include eye pain, vomiting, cloudy vision, halos, light sensitivity, distance vision problems, headaches, and others. The end users of these treatments include clinics, hospitals, and other healthcare facilities.

The night blindness treatment market research report is one of a series of new reports from The Business Research Company that provides night blindness treatment market statistics, including the night blindness treatment industry global market size, regional shares, competitors with night blindness treatment market share, detailed night blindness treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the night blindness treatment industry. These night blindness treatment market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The night blindness treatment market size has grown strongly in recent years. It will grow from $3.72 billion in 2023 to $3.95 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The increase observed in the historic period can be attributed to several factors, including a higher prevalence of vitamin A deficiency, an expanding geriatric population susceptible to night vision issues, the growth of healthcare infrastructure, a greater emphasis on nutritional interventions for vision health, and a rising incidence of retinitis pigmentosa.

The night blindness treatment market size is expected to see strong growth in the next few years. It will grow to $5.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth projected for the forecast period can be attributed to several factors, the rising adoption of advanced diagnostic technologies, increasing awareness campaigns regarding eye health, a growing demand for personalized medicine, the expansion of eye care clinics and facilities, and advancements in healthcare infrastructure. Major trends anticipated during this period include the adoption of cutting-edge diagnostic technologies, the implementation of personalized treatments, the development of gene therapy and stem cell treatments, the integration of wearable technology for real-time monitoring, and the establishment of multi-disciplinary clinics.

The growing incidence of cataracts is anticipated to drive the expansion of the night blindness treatment market. Cataracts occur when the lens of the eye becomes cloudy, impairing vision. Factors such as increased exposure to ultraviolet (UV) light, smoking, and poor diet contribute to cataract development. Cataracts diminish the eye's ability to discern different shades of light and dark, which is essential for night vision. This reduced contrast sensitivity makes it more challenging to navigate and identify objects in low-light settings. For instance, in July 2023, according to the 2021-23 National UK Eye Care Statistics Survey conducted by the Well-being of Future Generations Act (WFG), a UK-based government agency, there were approximately 16,500 cataract admissions in 2022-23, marking a 23.7% increase from the previous year. Consequently, the rise in cataract cases is fueling growth in the night blindness treatment market.

Key players in the night blindness treatment market are focusing on developing innovative genetic therapies to address the genetic mutations causing the condition, aiming to improve treatment outcomes. Genetic therapies target and repair specific genetic mutations affecting retinal function, potentially restoring vision in those with inherited retinal disorders such as retinitis pigmentosa. For instance, HuidaGene Therapeutics, a US-based clinical-stage biotech firm, introduced HG004 in August 2023. This gene therapy is designed to treat inherited retinal diseases such as Leber's congenital amaurosis and has shown superior results over existing treatments in preclinical studies, aiming to restore retinal function and alleviate night blindness.

In January 2022, Eluminex Biosciences, a Chinese biotechnology company, acquired global development and commercialization rights for Zuretinol (zuretinol acetate) from Retinagenix Holdings LLC for an undisclosed sum. This acquisition enables Eluminex Biosciences to enhance its retinal disease pipeline and develop innovative, non-surgical treatments for vision-threatening conditions such as Leber's congenital amaurosis (LCA) and retinitis pigmentosa (RP), offering potential solutions for the entire retina and both eyes simultaneously. Retinagenix Holdings, a US-based company, is also working on treatments for night blindness.

Major companies operating in the night blindness treatment market are Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Bayer AG, Abbott Laboratories, Novartis AG, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Eisai Co. Ltd, Cipla Inc., Nature's Way, Spark Therapeutics Inc., Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc., Swanson Health Products, NOW Foods

North America was the largest region in the night blindness treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the night blindness treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the night blindness treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The night blindness treatment market consists of revenues earned by entities by providing services such as diagnostic services, medical management and consultation, surgical interventions, and genetic counseling and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The night blindness treatment market also includes sales of night vision goggles, retinal implants and prosthetics, electroretinography (ERG) systems, vitamin A supplements, and intraocular injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Night Blindness Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on night blindness treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for night blindness treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The night blindness treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment: Medication; Surgery; Other Treatments
2) By Diagnosis: Blood Tests; Color Vision Testing; Pupil Light Reflex; Refraction; Retinal Exam; Electroretinogram (ERG); Other Diagnoses
3) By Symptom: Eye Pain; Vomiting; Cloudy Vision; Halos; Light Sensitivity; Distance Vision Problem; Headache; Other Symptoms
4) By End User: Clinic; Hospital; Other End Users
Companies Mentioned: Johnson & Johnson Private Limited; F. Hoffmann-La Roche Ltd.; Bayer AG; Abbott Laboratories; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r19727

1. Executive Summary

2. Night Blindness Treatment Market Characteristics

3. Night Blindness Treatment Market Trends And Strategies

4. Night Blindness Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Night Blindness Treatment Market Size and Growth

5.1. Global Night Blindness Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Night Blindness Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Night Blindness Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Night Blindness Treatment Market Segmentation

6.1. Global Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Medication
Surgery
Other Treatments
6.2. Global Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Blood Tests
Color Vision Testing
Pupil Light Reflex
Refraction
Retinal Exam
Electroretinogram (ERG)
Other Diagnoses
6.3. Global Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Eye Pain
Vomiting
Cloudy Vision
Halos
Light Sensitivity
Distance Vision Problem
Headache
Other Symptoms
6.4. Global Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinic
Hospital
Other End Users

7. Night Blindness Treatment Market Regional And Country Analysis

7.1. Global Night Blindness Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Night Blindness Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Night Blindness Treatment Market

8.1. Asia-Pacific Night Blindness Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Night Blindness Treatment Market

9.1. China Night Blindness Treatment Market Overview
9.2. China Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Night Blindness Treatment Market

10.1. India Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Night Blindness Treatment Market

11.1. Japan Night Blindness Treatment Market Overview
11.2. Japan Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Night Blindness Treatment Market

12.1. Australia Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Night Blindness Treatment Market

13.1. Indonesia Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Night Blindness Treatment Market

14.1. South Korea Night Blindness Treatment Market Overview
14.2. South Korea Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Night Blindness Treatment Market

15.1. Western Europe Night Blindness Treatment Market Overview
15.2. Western Europe Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Night Blindness Treatment Market

16.1. UK Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Night Blindness Treatment Market

17.1. Germany Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Night Blindness Treatment Market

18.1. France Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Night Blindness Treatment Market

19.1. Italy Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Night Blindness Treatment Market

20.1. Spain Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Night Blindness Treatment Market

21.1. Eastern Europe Night Blindness Treatment Market Overview
21.2. Eastern Europe Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Night Blindness Treatment Market

22.1. Russia Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Night Blindness Treatment Market

23.1. North America Night Blindness Treatment Market Overview
23.2. North America Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Night Blindness Treatment Market

24.1. USA Night Blindness Treatment Market Overview
24.2. USA Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Night Blindness Treatment Market

25.1. Canada Night Blindness Treatment Market Overview
25.2. Canada Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Night Blindness Treatment Market

26.1. South America Night Blindness Treatment Market Overview
26.2. South America Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Night Blindness Treatment Market

27.1. Brazil Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Night Blindness Treatment Market

28.1. Middle East Night Blindness Treatment Market Overview
28.2. Middle East Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Night Blindness Treatment Market

29.1. Africa Night Blindness Treatment Market Overview
29.2. Africa Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Night Blindness Treatment Market Competitive Landscape And Company Profiles

30.1. Night Blindness Treatment Market Competitive Landscape
30.2. Night Blindness Treatment Market Company Profiles
- 30.2.1. Johnson & Johnson Private Limited
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Abbott Laboratories
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Night Blindness Treatment Market Other Major And Innovative Companies

31.1. Boehringer Ingelheim
31.2. Regeneron Pharmaceuticals Inc.
31.3. Astellas Pharma Inc.
31.4. Biogen Inc.
31.5. Bausch Health Companies Inc.
31.6. Eisai Co. Ltd
31.7. Cipla Inc.
31.8. Nature's Way
31.9. Spark Therapeutics Inc.
31.10. Garden of Life
31.11. Apellis Pharmaceuticals Inc
31.12. Solgar
31.13. Acucela Inc.
31.14. Swanson Health Products
31.15. NOW Foods

32. Global Night Blindness Treatment Market Competitive Benchmarking

33. Global Night Blindness Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Night Blindness Treatment Market

35. Night Blindness Treatment Market Future Outlook and Potential Analysis

35.1 Night Blindness Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Night Blindness Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Night Blindness Treatment Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer